| 1 |
What is the primary goal of the article according to its introduction?
|
To explore advancements, applications, and challenges of generative AI in medical imaging |
|
The source is the Introduction section of the first attached PDF document.
Specifically, look at the final sentence of the introductory paragraphs: "This paper provides a comprehensive overview of synthetic data in medical imaging and critically analyses the advancements, applications, and challenges of this field
|
I summary of the whole page and it perfectly mirrors the author's stated scope in the introduction. The paper is explicitly designed to look at how Generative AI has moved forward , how it is being used , and what is holding it back.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
How do generative AI models differ from traditional discriminative models in healthcare applications?
|
Generative models produce new data rather than only classify or interpret |
|
The primary characteristic that defines Generative Al is its ability to generate or create entirely new, synthetic data (such as a realistic synthetic MRI scan or a new medical text summary).
|
Traditional Discriminative Models look at existing data and predict a label, category, or probability. For example, given a chest X-ray and the Generative Models learn the underlying structure of the data so they can produce completely new instances that look exactly like the training data. For example, they can generate new, highly realistic chest X-rays to expand a training dataset.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What is meant by the term “model as a dataset”?
|
Sharing trained model weights instead of raw data |
|
This concept is detailed in the "Promises of synthetic data" section of the attached paper. The term "model as a dataset" refers to a privacy-preserving strategy where researchers share a fully trained generative model (the weights and architecture) rather than distributing the original, sensitive patient data.
|
A "model" acting "as a dataset" means the mathematical file (the trained model weights) functions as the source from which data is drawn.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which statement correctly distinguishes physics-informed and statistical models?
|
Physics-informed models incorporate biological or physical principles |
|
Physics-informed models incorporate established scientific laws, such as thermodynamics, fluid dynamics, or biological rules, into the AI's design. This helps guarantee that its outputs are realistic and mathematically sound. Statistical models focus solely on identifying mathematical patterns, correlations, and probabilities in the training data, without an understanding of the laws of physics.
|
The term "physics-informed" literally defines itself—it is a model that has been "informed" or shaped by the laws of physics.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
According to the article, what does the “image generation trilemma” describe?
|
Trade-offs among image diversity, quality, and speed |
|
The “image generation trilemma” is a well-known concept in generative AI that describes the technical challenge of trying to achieve three ideal properties simultaneously: high sample quality, high mode diversity, and fast sampling speed.
|
In computer science, a "trilemma" refers to a three-way trade-off, which matches the balance of diversity, quality, and speed perfectly.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is the Human Turing Test used for in medical image synthesis?
|
To assess realism of synthetic medical images by experts |
|
A"Human Turing Test” involves having human medical experts, like radiologists or clinicians, examine a combination of real and AI-generated medical images. If the experts cannot consistently identify which images are real and which are synthetic, the generative model passes the test. This demonstrates that the synthetic images reach a very high standard of clinical realism.
|
Speed, mathematical similarity scores, and data anonymization are measured using algorithms and software code, not humans.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which of the following is NOT mentioned as a potential benefit of synthetic data in healthcare?
|
Eliminating all medical biases permanently |
|
While synthetic data helps reduce data scarcity and mitigate certain imbalances, it cannot eliminate all medical biases permanently.
|
The other three options—Enhancing Data Diversity, Preserving Patient Privacy, and Facilitating Multi-Centre Collaborations—are explicitly highlighted in the papers as major benefits of using synthetic datasets.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one major ethical concern associated with generative AI in medical imaging?
|
Data copying and patient reidentification |
|
If a generative model is too good at learning from the data it was trained on it might. Copy special things about real patients. This is a problem because it could let people figure out who the patients are. That means private health information could get out and this is not allowed by laws, like HIPAA or GDPR that are supposed to protect privacy.
|
Those options are incorrect because they are just technical facts, computer speed issues, or reasons for using AI, rather than actual moral violations that harm patient privacy.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What regulatory precedent did the article cite for synthetic data technologies?
|
FDA clearance of synthetic MRI as image-processing software |
|
The article cited the FDA Clearance Of Synthetic MRI As Image-Processing Software as the regulatory precedent for synthetic data technologies.
|
The text says that the FDA looked at these technologies like software that processes images not like new ways of doing things. This means they had to do a lot of testing to show that doctors who read images, called radiologists can do their job as well with fake images as they can with real ones. The FDA wanted to make sure that the doctors were just as good, at diagnosing problems when they used images as when they used regular images.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is the main purpose of the article?
|
To compare and evaluate ASCVD risk prediction models in East Asia |
|
The article is a state-of-the-art review that details, compares, and highlights the limitations of various cardiovascular risk prediction calculators used within East Asian populations.
|
Look at the title and abstract; the text explicitly reviews and contrasts how China, Japan, and Korea predict cardiovascular risk.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which of the following models was originally developed for a Western population?
|
Framingham Risk Score |
|
The Framingham Risk Score was developed from a famous U.S. community cohort study, whereas the other options were created using native East Asian data.
|
Identify which model is famously from the United States rather than China, Japan, or Korea.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why might Western-based risk prediction models overestimate ASCVD risk in East Asian populations?
|
East Asians have lower baseline incidence of ASCVD |
|
Western models overestimate risk because East Asian populations historically have a much lower actual baseline incidence of coronary heart disease compared to Western populations.
|
Overestimation happens when a formula expects a disease to happen more frequently than it actually does in a specific group.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is the key advantage of the China-PAR model compared to Western-based models?
|
It was calibrated using national data representing diverse regions in China |
|
Explanation in one sentence: The China-PAR model's key advantage is that it was built and validated using large-scale, contemporary cohort data from actual Chinese populations to ensure geographic and regional accuracy.
|
The text notes that using local, contemporary country data fixes the over prediction issues of Western models.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following variables is not typically included in ASCVD risk prediction models discussed in the article?
|
Genetic ancestry markers |
|
Traditional risk tools predict heart disease using clinical variables like age, blood pressure, cholesterol, and smoking habits rather than genetic ancestry markers.
|
Traditional and population-specific risk scores look at standard clinical health markers and behavioral habits rather than checking your DNA or genetic ancestry.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is a major difference between the Suita Score and the Framingham Risk Score?
|
Suita Score was designed for a Japanese population using local epidemiological data |
|
The Suita Score was specifically created using local epidemiological data from a Japanese cohort to accurately reflect that population's specific cardiovascular risk profile.
|
Look at where the data comes from; the Framingham score comes from a U.S. town, while the Suita score was specifically created using data from people in Japan to better fit their unique health profiles.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what is a potential benefit of developing East Asia–specific risk models?
|
They improve accuracy and reduce overestimation of risk |
|
Developing East Asia-specific risk models helps correct the problem where Western equations calculate a risk score that is falsely high for Asian individuals.
|
Because Western models assume everyone has a higher baseline rate of coronary artery disease, using local models stops doctors from falsely labeling healthy East Asian patients as high-risk.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Which factor was highlighted as influencing ASCVD risk differences among East Asian countries?
|
Cultural and dietary variations, such as salt intake and lifestyle |
|
Distinct cultural habits, regional lifestyles, and dietary variations like salt intake cause notable differences in cardiovascular risks even among different East Asian nations.
|
Even though China, Japan, and Korea are close geographically, their unique everyday habits—like eating patterns and high-salt foods—powerfully change their specific heart disease patterns.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What future direction does the article suggest for improving ASCVD risk prediction?
|
Using multimodal AI-based prediction integrated with regional data |
|
The article concludes that the future of risk prediction lies in leveraging advanced artificial intelligence to combine multi-omics, lifestyle, and regional data for highly personalized cardiovascular assessments.
|
Look for modern technological solutions mentioned at the end of the text; the article suggests upgrading traditional scores by combining artificial intelligence with local clinical data.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Which statement best explains the key difference in how VAEs, GANs, and DDPMs generate medical images according to the figure?
|
DDPMs iteratively remove noise through reverse diffusion rather than using encoder–decoder or discriminator structures. |
|
Unlike VAEs which use latent space encoding or GANs which use an adversarial discriminator, DDPMs work by gradually converting pure noise back into a clean image using a reverse diffusion process.
|
I focus at how each AI model handles data in the diagram; Variational Autoencoders (VAEs) map to a hidden space, Generative Adversarial Networks (GANs) fight a real-vs-fake battle, but Denoising Diffusion Probabilistic Models (DDPMs) step-by-step clean a noisy image.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Which of the following best explains the trend shown in Figure comparing age-standardized and crude CVD mortality rates among East Asian countries?
|
Despite differences in age structures, Japan maintains low mortality rates in both measures, suggesting effective prevention and healthcare systems. |
|
The data clearly shows Japan consistently achieving the lowest cardiovascular death rates across both demographic metrics, reflecting the superior performance of its chronic disease prevention and healthcare delivery systems.
|
Compare the bars for each country; Japan clearly stands out at the bottom of the graph with the lowest bars for both crude and age-standardized mortality, proving its public health measures work incredibly well.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|